Cosmos Health Inc COSM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants
-
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
-
Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program
-
Cosmos Health Announces Withdrawal of Registration Statement on Form S-1
-
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months
-
Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed
-
Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness
-
Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months
Trading Information
- Previous Close Price
- $0.23
- Day Range
- $0.23–0.24
- 52-Week Range
- $0.16–1.31
- Bid/Ask
- $0.23 / $0.23
- Shares Outstanding
- 62.08M
- Market Cap
- $14.89M
- Volume/Avg
- 166,701 / 9M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 163
- Website
- https://www.cosmoshealthinc.com
Valuation
|
Metric
|
COSM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.59 |
Price/Sales | 0.12 |
Price/Cash Flow | — |
Price/Earnings
COSM
Financial Strength
|
Metric
|
COSM
|
|---|---|
Quick Ratio | 0.63 |
Current Ratio | 1.08 |
Interest Coverage | −5.61 |
Quick Ratio
COSM
Profitability
|
Metric
|
COSM
|
|---|---|
Return on Assets (Normalized) | −19.62% |
Return on Equity (Normalized) | −54.67% |
Return on Invested Capital (Normalized) | −23.74% |
Return on Assets
COSM
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|J#VskbL | LOCK|%p^G | $99B | |||
| Cencora Inc
COR
| LOCK|zF%?nB& | LOCK|<>?Y | $60B | |||
| Cardinal Health Inc
CAH
| LOCK|&mWCL%p | LOCK|%cl%% | $54B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|w$dk | $24B | |||
| Henry Schein Inc
HSIC
| LOCK|&Qh#kQ | LOCK|s&syP | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|@gw | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|$y | $7B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|^l | $7B | |||
| Medipal Holdings Corp ADR
MAHLY
| — | LOCK|Tc$ | $4B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|&K | $4B |
United States